|
RFT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71707092988527E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85670367969237E-11 |
| Normal-vs-Stage2 |
2.25439999999022E-05 |
| Normal-vs-Stage3 |
2.63344901441087E-13 |
| Normal-vs-Stage4 |
1.01590003076524E-09 |
| Stage1-vs-Stage2 |
5.946400E-01 |
| Stage1-vs-Stage3 |
1.759980E-02 |
| Stage1-vs-Stage4 |
1.153760E-01 |
| Stage2-vs-Stage3 |
4.240200E-02 |
| Stage2-vs-Stage4 |
1.141800E-01 |
| Stage3-vs-Stage4 |
8.305200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-16 |
| Normal-vs-AfricanAmerican |
3.006100E-02 |
| Normal-vs-Asian |
1.50479999572184E-08 |
| Caucasian-vs-AfricanAmerican |
2.827600E-02 |
| Caucasian-vs-Asian |
3.470000E-01 |
| AfricanAmerican-vs-Asian |
8.528000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.51785267582727E-12 |
| Normal-vs-Female |
4.52826665053863E-12 |
| Male-vs-Female |
2.736200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.42920120183021E-11 |
| Normal-vs-Age(41-60Yrs) |
1.04789998900401E-09 |
| Normal-vs-Age(61-80Yrs) |
1.59530166854438E-11 |
| Normal-vs-Age(81-100Yrs) |
8.189900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.389400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.067600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.788000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.440800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.064800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.582600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.60229999957818E-07 |
| Classical-VS-Follicular |
3.740200E-01 |
| Classical-VS-Other |
2.943400E-01 |
| Classical-VS-Normal |
3.56048523997288E-12 |
| Tall-VS-Follicular |
3.845800000013E-06 |
| Tall-VS-Other |
2.861400E-01 |
| Tall-VS-Normal |
9.2148511043888E-15 |
| Follicular-VS-Other |
2.606800E-01 |
| Follicular-VS-Normal |
3.22149999998356E-06 |
| Other-VS-Normal |
9.787500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8672999813063E-09 |
| Normal-vs-N1 |
1.92812432686651E-12 |
| N0-vs-N1 |
5.616400E-04 |
|
|
